Posted:
#1
Probably a great speculative buy below 5, like DNDN with a 2-3 year horizon.
ITMN
Views: 204
Posts: 2
Posted:
#2
Yikes
UPDATE: FDA Doesn't Approve Proposed Intermune Lung Drug
74 minutes ago - Dow Jones News
(Adds company comment, stock price details)
By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES
WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration declined to approve Esbriet, a proposed lung drug from
The FDA wants another clinical trial of the drug, also known generically as pirfenidone, InterMune said. The product was developed to treat a lung condition known as idiopathic pulmonary fibrosis, which is caused when tissue in the lungs becomes thick and scarred.
InterMune plunged 81% to $8.46 in after-market trading, after more than tripling since early March, when it traded below $15. It was halted earlier Tuesday at $45.44.
InterMune plans to meet with the FDA as soon as possible to "understand their points of view" in the next 60 to 90 days, the company said on a conference call Tuesday.
Hot Forum Topics
